Multi-Objective Optimization Method for Signalized Intersections in Intelligent Traffic Network.

Urban intersections are one of the most common sources of traffic congestion. Especially for multiple intersections, an appropriate control method should be able to regulate the traffic flow within the control area. The intersection signal-timing problem is crucial for ensuring efficient traffic operations, with the key issues being the determination of a traffic model and the design of an optimization algorithm. So, an optimization method for signalized intersections integrating a multi-objective model and an NSGAIII-DAE algorithm is established in this paper. Firstly, the multi-objective model is constructed including the usual signal control delay and traffic capacity indices. In addition, the conflict delay caused by right-turning vehicles crossing straight-going non-motor vehicles is considered and combined with the proposed algorithm, enabling the traffic model to better balance the traffic efficiency of intersections without adding infrastructure. Secondly, to address the challenges of diversity and convergence faced by the classic NSGA-III algorithm in solving traffic models with high-dimensional search spaces, a denoising autoencoder (DAE) is adopted to learn the compact representation of the original high-dimensional search space. Some genetic operations are performed in the compressed space and then mapped back to the original search space through the DAE. As a result, an appropriate balance between the local and global searching in an iteration can be achieved. To validate the proposed method, numerical experiments were conducted using actual traffic data from intersections in Jinzhou, China. The numerical results show that the signal control delay and conflict delay are significantly reduced compared with the existing algorithm, and the optimal reduction is 33.7% and 31.3%, respectively. The capacity value obtained by the proposed method in this paper is lower than that of the compared algorithm, but it is also 11.5% higher than that of the current scheme in this case. The comparisons and discussions demonstrate the effectiveness of the proposed method designed for improving the efficiency of signalized intersections.

One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: A randomized controlled trial.

OBJECTIVES: The 3HP regimen, consisting of 12 doses of weekly rifapentine plus isoniazid, improves completion rate of latent tuberculosis infection (LTBI) treatment, but flu-like symptoms are common. The novel 1HP regimen, involving daily rifapentine plus isoniazid for 28 days, has demonstrated low toxicity in Human Immunodeficiency Virus (HIV)-infected populations. We aimed to investigate whether 1HP has a lower incidence rate of systemic drug reaction (SDR) compared with 3HP during treatment in non-HIV populations. METHODS: This randomised, multicentre trial compared the completion rate and risks of SDRs of 1HP and 3HP in aged ≥13-years non-HIV subjects with LTBI between September 2019 and September 2023 (ClinicalTrials.gov: NCT04094012). We also investigated associations between SDRs and plasma levels of drugs and their metabolites. RESULTS: A total of 251 and 239 individuals were randomised to 1HP and 3HP groups, respectively, with completion rates of 82.9% (208/251) and 84.5% (202/239), respectively. Among them, 12.7% (32/251) and 10.9% (26/239) of 1HP and 3HP groups experienced SDRs, respectively (p=0.522), predominantly urticaria in 1HP group (59.4% [19/32]) and flu-like syndrome in 3HP group (80.8% [21/26]). Among participants experiencing SDRs, 43.8% (14/32) and 34.6% (9/26) in 1HP and 3HP groups, respectively, completed treatment (p=0.470). Cutaneous reactions were more common in 1HP than 3HP group (32.7% [82/251] vs. 13.0% [31/239], p<0.001). In 1HP group, urticaria was associated with a higher plasma desacetyl-rifapentine level (ug/mL) at both 2 (median [interquartile range]: 36.06 [17.46-50.79] vs. 22.94 [14.67-31.65], p=0.018) and 6 hours (26.13 [15.80-53.06] vs. 29.83 [18.13-34.01], p=0.047) after dosing. CONCLUSIONS: In non-HIV population, the incidence rate of SDR under 1HP is not lower than 3HP. Notably, urticaria, rather than flu-like syndrome, was the predominant SDR associated 1HP. The findings of this study underscore the feasibility of 1HP regimen in non-HIV populations with a high completion rate exceeding 80%.

Qualitation and Quantitation on Microplasma Jet for Bacteria Inactivation.

In this work, a self-made microplasma jet system was used to conduct the qualitation and quantitation of inactivation with Escherichia coli as the target bacteria. The logarithmic concentration and the size of antimicrobial rings served as the evaluation parameters, respectively. The effect of various parameters on inactivation effect was studied. The results showed that the majority of bacteria had been inactivated in 30 s. The inactivation effect enhanced and then weakened with the increase of air flow rate, and receded as the extension of treatment distance. The effect with different carrier gases showed as follows: oxygen > air > nitrogen > argon. Meanwhile, the effect of different components of microplasma was studied in the optimum conditions (The flow rate was 5 L/min; inactivation distance was 2 cm). The results showed that electrically neutral active species was the main factor of inactivation rather than heating effect, ultraviolet radiation and charged particles. Finally the experiments of thallus change proved that microplasma jet had etching effect on cell membrane. It also found that microplasma could degrade organic material like protein. Furthermore, the images of scanning electron microscope (SEM) revealed the change of cell morphology step by step in the whole process of inactivation.

Unprecedent aminophysalin from Physalis angulata.

The 95% ethanol extract of the whole plant of Physalis angulata Linn. afforded one new skeletal physalin named aminophysalin A (1) and one new naturally occurring 5ß-hydroxy-6a-chloro-5,6-dihydrophysalin B (2), together with five known physalins (3-7). Their structures were elucidated through MS, IR, NMR spectroscopy analyses and X-ray crystallography. Aminophysalin A (1) had an absolutely unusual structural feature in the chemistry of physalins with a nitrogen atom. Compounds 1-7 were evaluated for quinone reductase activities in hepa 1c1c7 cells. Physalin H (6) showed strong quinone reductase induction activity with IR (Induction ratio, QR induction activity) value of 3.74±0.02, using 4-bromoflavone as a positive control substance (2.17±0.01, 10 µg/mL), while compounds 1, 2, 3, 5 showed weak quinone reductase induction activity.